東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Pharmacotherapy in aortic disease

Evangelista, Arturo.

FindBook

Google Book

Amazon

博客來

Pharmacotherapy in aortic disease

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Pharmacotherapy in aortic disease/ edited by Arturo Evangelista, Christoph A. Nienaber.
其他作者:	Evangelista, Arturo.
出版者:	Cham :Springer International Publishing : : 2015.,
面頁冊數:	xii, 269 p. :ill., digital ;24 cm.
內容註:	Aortic atherosclerosis as an embolic source -- Aortitis -- Aortic aneurysm -- Marfan Syndrome -- Acute Aortic Syndrome -- Chronic aortic dissection.
Contained By:	Springer eBooks
標題:	Aorta - Diseases -
電子資源:	http://dx.doi.org/10.1007/978-3-319-09555-4
ISBN:	9783319095554 (electronic bk.)

Pharmacotherapy in aortic disease
Pharmacotherapy in aortic disease[electronic resource] /edited by Arturo Evangelista, Christoph A. Nienaber. - Cham :Springer International Publishing :2015. - xii, 269 p. :ill., digital ;24 cm. - Current cardiovascular therapy ;7. - Current cardiovascular therapy ;5..

Aortic atherosclerosis as an embolic source -- Aortitis -- Aortic aneurysm -- Marfan Syndrome -- Acute Aortic Syndrome -- Chronic aortic dissection.

This book is driven by the considerable progress made by novel imaging techniques in understanding the pathophysiology and evolution of aortic disease and its diagnosis. Despite the lack of symptoms in stable conditions, most aortic diseases have a high morbidity and mortality. New therapeutic strategies such as endovascular treatment and surgical techniques have appeared to improve conventional surgery in advanced phases of the disease, but until recently, medical treatment has focused on the control of cardiovascular risk factors using beta-blockers to reduce aortic wall stress by reducing blood pressure and heart rate. Pharmacotherapy in Aortic Disease updates the reader on the new medical treatment that are changing the natural history of these diseases. Leading experts have created a critical in-depth, yet concise, analysis of the available medical treatments for different aortic disease entities. Both basic research studies and clinical trials discussed in this book serve as a base for improving therapeutic management, delaying the need for surgery, and prolonging survival in these patients.

ISBN: 9783319095554 (electronic bk.)

Standard No.: 10.1007/978-3-319-09555-4doiSubjects--Topical Terms:

2132331
Aorta
--Diseases

LC Class. No.: RC691

Dewey Class. No.: 616.138

Pharmacotherapy in aortic disease
LDR:02241nmm a2200325 a 4500 001 1993834
003 DE-He213
005 20150723153717.0
006 m d
007 cr nn 008maaau
008 151019s2015 gw s 0 eng d
020 $a 9783319095554 (electronic bk.)
020 $a 9783319095547 (paper)
024 7 $a 10.1007/978-3-319-09555-4 $2 doi
035 $a 978-3-319-09555-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC691
072 7 $a MJD $2 bicssc
072 7 $a MED010000 $2 bisacsh
082 0 4 $a 616.138 $2 23
090 $a RC691 $b .P536 2015
245 0 0 $a Pharmacotherapy in aortic disease $h [electronic resource] / $c edited by Arturo Evangelista, Christoph A. Nienaber.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a xii, 269 p. : $b ill., digital ; $c 24 cm.
490 1 $a Current cardiovascular therapy ; $v 7
505 0 $a Aortic atherosclerosis as an embolic source -- Aortitis -- Aortic aneurysm -- Marfan Syndrome -- Acute Aortic Syndrome -- Chronic aortic dissection.
520 $a This book is driven by the considerable progress made by novel imaging techniques in understanding the pathophysiology and evolution of aortic disease and its diagnosis. Despite the lack of symptoms in stable conditions, most aortic diseases have a high morbidity and mortality. New therapeutic strategies such as endovascular treatment and surgical techniques have appeared to improve conventional surgery in advanced phases of the disease, but until recently, medical treatment has focused on the control of cardiovascular risk factors using beta-blockers to reduce aortic wall stress by reducing blood pressure and heart rate. Pharmacotherapy in Aortic Disease updates the reader on the new medical treatment that are changing the natural history of these diseases. Leading experts have created a critical in-depth, yet concise, analysis of the available medical treatments for different aortic disease entities. Both basic research studies and clinical trials discussed in this book serve as a base for improving therapeutic management, delaying the need for surgery, and prolonging survival in these patients.
650 0 $a Aorta $x Diseases $x Chemotherapy. $3 2132331
650 0 $a Cardiovascular pharmacology. $3 2056157
650 1 4 $a Medicine & Public Health. $3 890906
650 2 4 $a Cardiology. $3 861477
650 2 4 $a Pharmacotherapy. $3 1978501
650 2 4 $a Cardiac Surgery. $3 894362
700 1 $a Evangelista, Arturo. $3 2132329
700 1 $a Nienaber, Christoph A. $3 2132330
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Current cardiovascular therapy ; $v 5. $3 2131365
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-09555-4
950 $a Medicine (Springer-11650)